Polen Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-60,661
| Closed | -$5.26M | – | 259 |
|
|
2026
Q1 | $5.26M | Sell |
60,661
-23,839
| -28% | -$2.28M | 0.04% | 58 |
|
|
2025
Q4 | $8.12M | Sell |
84,500
-40,456
| -32% | -$3.93M | 0.03% | 46 |
|
|
2025
Q3 | $11.9M | Sell |
124,956
-109,930
| -47% | -$10.1M | 0.04% | 45 |
|
|
2025
Q2 | $20.5M | Sell |
234,886
-394,597
| -63% | -$33.5M | 0.06% | 39 |
|
|
2025
Q1 | $56.6M | Sell |
629,483
-152,995
| -20% | -$13.7M | 0.18% | 34 |
|
|
2024
Q4 | $62.5M | Sell |
782,478
-240,551
| -24% | -$20.8M | 0.17% | 31 |
|
|
2024
Q3 | $92.1M | Sell |
1,023,029
-26,940
| -3% | -$2.27M | 0.24% | 29 |
|
|
2024
Q2 | $82.6M | Sell |
1,049,969
-15,640
| -1% | -$1.28M | 0.21% | 31 |
|
|
2024
Q1 | $92.9M | Buy |
1,065,609
+82,105
| +8% | +$7.01M | 0.21% | 30 |
|
|
2023
Q4 | $81M | Buy |
983,504
+188,715
| +24% | +$14.4M | 0.2% | 33 |
|
|
2023
Q3 | $62.3M | Buy |
794,789
+12,876
| +2% | +$1.08M | 0.16% | 33 |
|
|
2023
Q2 | $68.9M | Sell |
781,913
-20,461
| -3% | -$1.76M | 0.17% | 29 |
|
|
2023
Q1 | $64.7M | Sell |
802,374
-11,617
| -1% | -$947K | 0.17% | 29 |
|
|
2022
Q4 | $63.3M | Sell |
813,991
-97,484
| -11% | -$7.9M | 0.18% | 29 |
|
|
2022
Q3 | $73.6M | Buy |
911,475
+9,576
| +1% | +$861K | 0.21% | 30 |
|
|
2022
Q2 | $80.9M | Sell |
901,899
-47,890
| -5% | -$4.85M | 0.21% | 29 |
|
|
2022
Q1 | $105M | Sell |
949,789
-56,650
| -6% | -$5.98M | 0.21% | 29 |
|
|
2021
Q4 | $104M | Sell |
1,006,439
-6,747
| -0.7% | -$781K | 0.17% | 30 |
|
|
2021
Q3 | $127M | Buy |
1,013,186
+116,280
| +13% | +$15.1M | 0.23% | 28 |
|
|
2021
Q2 | $111M | Buy |
896,906
+9,457
| +1% | +$1.19M | 0.21% | 28 |
|
|
2021
Q1 | $105M | Buy |
887,449
+71,488
| +9% | +$8.38M | 0.24% | 28 |
|
|
2020
Q4 | $95.6M | Buy |
815,961
+107,360
| +15% | +$11.8M | 0.22% | 28 |
|
|
2020
Q3 | $73.6M | Buy |
708,601
+208,560
| +42% | +$20.9M | 0.2% | 28 |
|
|
2020
Q2 | $45.9M | Buy |
500,041
+87,182
| +21% | +$8.36M | 0.14% | 26 |
|
|
2020
Q1 | $37.2M | Buy |
412,859
+111,028
| +37% | +$11.8M | 0.16% | 26 |
|
|
2019
Q4 | $34.2M | Buy |
301,831
+83,829
| +38% | +$9.2M | 0.13% | 27 |
|
|
2019
Q3 | $23.7M | Buy |
218,002
+72,448
| +50% | +$7.56M | 0.11% | 25 |
|
|
2019
Q2 | $14.2M | Buy |
145,554
+33,156
| +29% | +$3.03M | 0.07% | 24 |
|
|
2019
Q1 | $10.2M | Buy |
112,398
+28,663
| +34% | +$2.57M | 0.05% | 24 |
|
|
2018
Q4 | $7.62M | Buy |
83,735
+13,730
| +20% | +$1.28M | 0.05% | 25 |
|
|
2018
Q3 | $6.89M | Buy |
70,005
+14,726
| +27% | +$1.36M | 0.04% | 26 |
|
|
2018
Q2 | $4.73M | Buy |
55,279
+4,452
| +9% | +$372K | 0.03% | 25 |
|
|
2018
Q1 | $4.08M | Buy |
50,827
+28,460
| +127% | +$2.35M | 0.03% | 28 |
|
|
2017
Q4 | $1.81M | Buy |
+22,367
| New | +$1.79M | 0.01% | 30 |
|
Other funds holding MDT
Polen Capital Management's MDT Position: Q2 2026 in Review
Polen Capital Management sold out of Medtronic (MDT) in Q2 2026, closing a stake of 60,661 shares — an estimated $5.26M sold.
Polen Capital Management first reported a position in MDT in Q4 2017 and held it in 34 quarters. The position peaked at $127M in Q3 2021. 2,124 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Polen Capital Management reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
- Polen Capital Management sold 60,661 Medtronic shares in Q2 2026, an estimated $5.26M.
- Polen Capital Management first reported a position in Medtronic in Q4 2017 and held it in 34 quarters.
- Polen Capital Management's Medtronic position peaked at $127M in Q3 2021.
- 2,124 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Polen Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.